Dong Wha Pharm Co. Ltd. | Mutual Funds
Mutual Funds that own Dong Wha Pharm Co. Ltd.
DFA Emerging Markets Small Cap Series
200,939
0.72%
0
0.03%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
192,758
0.69%
33,163
0.01%
04/30/2018
Government Pension Fund - Global (The)
82,904
0.3%
-33,031
0%
12/31/2017
RAM (Lux) Systematic Funds - Emerging Markets Equities
58,285
0.21%
58,285
0.02%
06/30/2017
DFA Dimensional Emerging Markets Value Fund
39,120
0.14%
-41,024
0%
01/31/2018
SPDR S&P International Small Cap ETF
32,068
0.12%
0
0.04%
09/06/2018
Luxcellence - Polunin Emerging Markets Technology Fund
24,000
0.09%
0
0.95%
06/30/2017
GMO Implementation Fund
18,472
0.07%
18,472
0%
02/28/2018
RAM (Lux) Systematic Funds - Long/Short Emerging Markets Eq.
13,123
0.05%
13,123
0.11%
06/30/2017
DFA Emerging Markets Social Core Equity Portfolio
9,743
0.04%
2,222
0.01%
04/30/2018
| Address |
19th Floor, STX Namsan Tower
Seoul SL 04637
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.dong-wha.co.kr |
| Updated |
07/08/2019 |
| Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. Its products include medicines for digesting, skin scars, general cold, gum treatment, high blood pressure, infection, controlling gastrointestinal tract, and others. The company was founded on September 25, 1897 and is headquartered in Seoul, South Korea. |
